ALTEOGEN (Korea) Performance
| 196170 Stock | KRW 305,500 8,500 2.86% |
The firm shows a Beta (market volatility) of 0.13, which signifies not very significant fluctuations relative to the market. As returns on the market increase, ALTEOGEN's returns are expected to increase less than the market. However, during the bear market, the loss of holding ALTEOGEN is expected to be smaller as well. ALTEOGEN currently shows a risk of 5.03%. Please confirm ALTEOGEN standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if ALTEOGEN will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days ALTEOGEN has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ALTEOGEN is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -126 B |
ALTEOGEN |
ALTEOGEN Relative Risk vs. Return Landscape
If you would invest 31,900,000 in ALTEOGEN on August 30, 2024 and sell it today you would lose (1,350,000) from holding ALTEOGEN or give up 4.23% of portfolio value over 90 days. ALTEOGEN is generating 0.05% of daily returns and assumes 5.0316% volatility on return distribution over the 90 days horizon. Simply put, 44% of stocks are less volatile than ALTEOGEN, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
ALTEOGEN Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ALTEOGEN's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ALTEOGEN, and traders can use it to determine the average amount a ALTEOGEN's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0099
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 196170 |
Estimated Market Risk
| 5.03 actual daily | 44 56% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ALTEOGEN is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ALTEOGEN by adding ALTEOGEN to a well-diversified portfolio.
ALTEOGEN Fundamentals Growth
ALTEOGEN Stock prices reflect investors' perceptions of the future prospects and financial health of ALTEOGEN, and ALTEOGEN fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ALTEOGEN Stock performance.
| Return On Equity | -0.0102 | |||
| Return On Asset | -0.0419 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | (0.48) % | |||
| Current Valuation | 3.27 T | |||
| Shares Outstanding | 13.58 M | |||
| Price To Sales | 15.11 X | |||
| Revenue | 41.12 B | |||
| EBITDA | (14.43 B) | |||
| Cash And Equivalents | 10.54 B | |||
| Total Debt | 1.07 B | |||
| Cash Flow From Operations | (9.42 B) | |||
| Total Asset | 260.34 B | |||
About ALTEOGEN Performance
By analyzing ALTEOGEN's fundamental ratios, stakeholders can gain valuable insights into ALTEOGEN's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ALTEOGEN has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ALTEOGEN has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about ALTEOGEN performance evaluation
Checking the ongoing alerts about ALTEOGEN for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ALTEOGEN help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ALTEOGEN had very high historical volatility over the last 90 days | |
| The company reported the revenue of 41.12 B. Net Loss for the year was (3.88 B) with profit before overhead, payroll, taxes, and interest of 8.08 B. | |
| ALTEOGEN has accumulated about 10.54 B in cash with (9.42 B) of positive cash flow from operations. | |
| Roughly 31.0% of the company shares are owned by insiders or employees |
- Analyzing ALTEOGEN's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ALTEOGEN's stock is overvalued or undervalued compared to its peers.
- Examining ALTEOGEN's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ALTEOGEN's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ALTEOGEN's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ALTEOGEN's stock. These opinions can provide insight into ALTEOGEN's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ALTEOGEN Stock analysis
When running ALTEOGEN's price analysis, check to measure ALTEOGEN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ALTEOGEN is operating at the current time. Most of ALTEOGEN's value examination focuses on studying past and present price action to predict the probability of ALTEOGEN's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ALTEOGEN's price. Additionally, you may evaluate how the addition of ALTEOGEN to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |